Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
British Journal of Haematology
|
September 15, 2025
Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm
Michal Nordkin, Nashwa Fadaos, Ronit Leiba, et al.
European Journal of Haematology
|
October 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study
Liat Shargian, Odelia Amit, Hanna Bernstine, et al.
Annals of Hematology
|
December 11, 2024
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab
Nashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, et al.
Antibodies (Basel, Switzerland)
|
August 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, et al.
Blood Advances
|
April 21, 2020
CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma
Meir Shamay, Jennifer A Kanakry, John S W Low, et al.
Leukemia & Lymphoma
|
September 14, 2017
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
Ohad S Bentur, Ronit Gurion, Anat Gafter-Gvili, et al.
Blood Advances
|
November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study
Tsila Zuckerman, Ron Ram, Luiza Akria, et al.
Cancer
|
August 12, 2023
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma
Osnat Bairey, Alisa Taliansky, Amir Glik, et al.
Cancer Research
|
March 18, 2010
Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen
Kris A Steinbrecher, Netanel A Horowitz, Elizabeth A Blevins, et al.
Haematologica
|
July 29, 2021
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
Ronit Gurion, Uri Rozovski, Gilad Itchaki, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
British Journal of Haematology
|
September 15, 2025
Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm
Michal Nordkin, Nashwa Fadaos, Ronit Leiba, et al.
European Journal of Haematology
|
October 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study
Liat Shargian, Odelia Amit, Hanna Bernstine, et al.
Annals of Hematology
|
December 11, 2024
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab
Nashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, et al.
Antibodies (Basel, Switzerland)
|
August 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, et al.
Blood Advances
|
April 21, 2020
CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma
Meir Shamay, Jennifer A Kanakry, John S W Low, et al.
Leukemia & Lymphoma
|
September 14, 2017
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
Ohad S Bentur, Ronit Gurion, Anat Gafter-Gvili, et al.
Blood Advances
|
November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study
Tsila Zuckerman, Ron Ram, Luiza Akria, et al.
Cancer
|
August 12, 2023
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma
Osnat Bairey, Alisa Taliansky, Amir Glik, et al.
Cancer Research
|
March 18, 2010
Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen
Kris A Steinbrecher, Netanel A Horowitz, Elizabeth A Blevins, et al.
Haematologica
|
July 29, 2021
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
Ronit Gurion, Uri Rozovski, Gilad Itchaki, et al.
Page
of 7